Pandemic Antiviral Discovery (PAD): Henipavirus

projects that seek to elucidate the molecular determinants of henipavirus replication, pathogenesis and transmission for the purpose of developing therapeutic discovery programs targeting virus and/or host-specific targets important for virus replication. Projects can be of both novel and exploratory nature and of later-stage validation/developmental nature.  Funding: A total of up to $10 million is allocated to this RfP where this may support 5 exploratory projects of ~$2 M or one later-stage validation project of ~$10 million.  (No overhead)

https://padinitiative.com/henipavirus-request-for-proposals-2022/